No Data
No Data
Express News | Ginkgo Bioworks Awarded $118M U.S. Government HHS Contract
Ginkgo Regains Compliance With NYSE Minimum Bid Price Requirement
NYSE to Commence Delisting Proceedings With Respect to the Warrants of Ginkgo Bioworks Holdings, Inc. (DNA.WS)
Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
Stocks Hitting All-time Highs: JPM, KO, LMT, UNH, and More
BTIG Maintains Ginkgo Bioworks(DNA.US) With Sell Rating, Maintains Target Price $7
No Data
No Data
QMengColdJoke : not even a resist… Possible a fraud and going to bankruptcy.
TechTrek Invest : I'm buying.